Back to top
more

Guardant Health (GH)

(Delayed Data from NSDQ)

$168.52 USD

168.52
1,517,526

-2.40 (-1.40%)

Updated Aug 27, 2026 04:00 PM ET

After-Market: $169.00 +0.48 (0.28%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Kevin Cook headshot

Bull of the Day: Guardant Health (GH)

by Kevin Cook

Cancer diagnostics provider just delivered 181% revenue growth and 18,500 tests to patients and labs

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for December 6th

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 6th

Zacks Equity Research

Spero Posts Preliminary Data on SPR720 for Pulmonary Disease

by Zacks Equity Research

Spero (SPRO) reports preliminary findings from a phase I first-in-human study on SPR720, presently being evaluated for the treatment of nontuberculous mycobacterial pulmonary disease.

Zacks Equity Research

Is Guardant Health (GH) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (GH) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for December 2nd

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 2nd

Zacks Equity Research

Zacks.com featured highlights include: Kirkland Lake Gold, Target and Guardant Health

by Zacks Equity Research

Zacks.com featured highlights include: Kirkland Lake Gold, Target and Guardant Health

Zacks Equity Research

Top 3 Momentum Anomaly Stocks to Buy for Healthy Profits

by Zacks Equity Research

These stocks are currently witnessing short-term pullback in a bull market. So, this could just be the perfect entry point for investors who are looking to enhance their portfolio returns.

Zacks Equity Research

Alkermes to Acquire Rodin Therapeutics, Boost CNS Pipeline

by Zacks Equity Research

Alkermes (ALKS) will acquire Rodin Therapeutics for an upfront cash payment of $100 million and up to $850 million in milestone payments.

Zacks Equity Research

Guardant Health Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor Guardant Health.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for November 12th

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 12th